Flávia Borelli Gomes Do Nascimento
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Flávia Borelli Gomes Do Nascimento has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Carolina Paula Jesus Kasa
Grupo de Apoio ao Adolescente e Criança com Câncer, Universidade Federal de São Paulo, São Paulo, Brazil, Brazil
1 shared publication - Eduardo Ladeia Leal
Grupo de Apoio ao Adolescente e Criança com Câncer, Universidade Federal de São Paulo, São Paulo, Brazil, Brazil
1 shared publication - Fábio Cardoso Cruz
Molecular and Behavioral Neuroscience Laboratory, Pharmacology Department, Universidade Federal de São Paulo, São Paulo, Brazil
1 shared publication - Mariana Martins Gonzaga Do Nascimento
Universidade Federal de Minas Gerais – UFMG. Belo Horizonte/MG, Brasil
1 shared publication - Paulo Caleb Junior Lima Santos
Department of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM-Unifesp)
1 shared publication - Thuane Sales Gonçalves
Department of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 December 2023
- Published by MDPI AG in Future Pharmacology
- Vol. 3 (4) , 916-925
Evaluations of NSAIDs and Opioids as Analgesics in Pediatric Oncology
As one of the leading causes of death in childhood, cancer also causes discomfort to pediatric patients. Even with guidelines for pain management, more than half of hospitalized children have intense and unrelieved pain. The present work aims to describe the intensity of pain and its pharmacological management in a pediatric oncology population. Patients aged 0 to 17 years old, diagnosed with cancer, who were admitted to a children’s oncology hospital and had well-documented data on pain management in their medical records were included. A total of 333 patients were included, mostly male (55.8%) with a mean age of 7.9 years. A substantial portion of the patient cohort (51.4%) initially reported experiencing pain of moderate intensity during the first assessment. Subsequently, following the pharmacological intervention, a significant proportion of patients (90.1%) reported complete alleviation of pain. The predominant pharmaceutical agents utilized for pain management encompassed metamizole (76.6%) and morphine (10.2%). All pharmacological interventions used were able to significantly reduce patients’ pain. This study underscores the utilization of different pharmacological classes to achieve notable reductions in pain intensity among patients grappling with severe pain.
- 1 December 2023
- Published by MDPI AG in Future Pharmacology
- Vol. 3 (4) , 916-925
Open AccessEvaluations of NSAIDs and Opioids as Analgesics in Pediatric Oncology
As one of the leading causes of death in childhood, cancer also causes discomfort to pediatric patients. Even with guidelines for pain management, more than half of hospitalized children have intense and unrelieved pain. The present work aims to describe the intensity of pain and its pharmacological management in a pediatric oncology population. Patients aged 0 to 17 years old, diagnosed with cancer, who were admitted to a children’s oncology hospital and had well-documented data on pain management in their medical records were included. A total of 333 patients were included, mostly male (55.8%) with a mean age of 7.9 years. A substantial portion of the patient cohort (51.4%) initially reported experiencing pain of moderate intensity during the first assessment. Subsequently, following the pharmacological intervention, a significant proportion of patients (90.1%) reported complete alleviation of pain. The predominant pharmaceutical agents utilized for pain management encompassed metamizole (76.6%) and morphine (10.2%). All pharmacological interventions used were able to significantly reduce patients’ pain. This study underscores the utilization of different pharmacological classes to achieve notable reductions in pain intensity among patients grappling with severe pain.